Ascendis Pharma A/S (ASND)
239.88
-25.04
(-9.45%)
USD |
NASDAQ |
Sep 15, 16:00
239.50
-0.38
(-0.16%)
After-Hours: 20:00
Ascendis Pharma Price : 239.88 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 265.00 | 265.50 | 260.00 | 264.92 | 417846.0 |
| Sep 11, 2026 | 263.34 | 266.34 | 259.48 | 263.52 | 443605.0 |
| Sep 10, 2026 | 260.00 | 262.17 | 258.01 | 261.23 | 505041.0 |
| Sep 09, 2026 | 270.89 | 272.37 | 260.75 | 260.81 | 497435.0 |
| Sep 08, 2026 | 263.41 | 272.47 | 262.32 | 270.09 | 653372.0 |
| Sep 04, 2026 | 267.96 | 271.14 | 265.22 | 270.56 | 723516.0 |
| Sep 03, 2026 | 266.94 | 272.44 | 265.80 | 271.12 | 1.019M |
| Sep 02, 2026 | 261.39 | 268.71 | 257.52 | 267.31 | 418296.0 |
| Sep 01, 2026 | 261.65 | 266.63 | 256.28 | 260.25 | 610604.0 |
| Aug 31, 2026 | 247.65 | 268.98 | 247.65 | 263.04 | 1.026M |
| Aug 28, 2026 | 248.11 | 250.23 | 246.30 | 247.91 | 314793.0 |
| Aug 27, 2026 | 249.73 | 250.69 | 248.41 | 249.36 | 189535.0 |
| Aug 26, 2026 | 252.84 | 252.84 | 249.16 | 250.25 | 237428.0 |
| Aug 25, 2026 | 253.01 | 256.60 | 251.32 | 252.99 | 333518.0 |
| Aug 24, 2026 | 256.35 | 256.35 | 247.03 | 251.95 | 329924.0 |
| Aug 21, 2026 | 253.62 | 257.88 | 252.87 | 253.29 | 363774.0 |
| Aug 20, 2026 | 256.65 | 260.98 | 253.21 | 254.81 | 533645.0 |
| Aug 19, 2026 | 255.00 | 261.61 | 251.11 | 259.62 | 541222.0 |
| Aug 18, 2026 | 246.47 | 253.55 | 245.68 | 248.85 | 452633.0 |
| Aug 17, 2026 | 246.33 | 250.62 | 242.00 | 247.40 | 607654.0 |
| Aug 14, 2026 | 243.63 | 249.52 | 240.64 | 248.50 | 650359.0 |
| Aug 13, 2026 | 250.38 | 251.43 | 244.12 | 246.23 | 1.061M |
| Aug 12, 2026 | 253.92 | 258.54 | 251.92 | 255.46 | 440053.0 |
| Aug 11, 2026 | 256.70 | 258.48 | 252.26 | 254.57 | 418491.0 |
| Aug 10, 2026 | 255.01 | 257.42 | 251.00 | 255.62 | 423479.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 3.05 |
| BioMarin Pharmaceutical, Inc. | 64.43 |
| Genmab A/S | 34.15 |
| Zealand Pharma A/S | 43.00 |
| Cellectis SA | 1.61 |
Price Related Metrics
| PE Ratio | 18.28 |
| PS Ratio | 12.53 |
| Price to Book Value | 9.592 |
| Price to Free Cash Flow | 39.33 |
| Earnings Yield | 5.47% |
| Market Cap | 15.75B |
| Operating PE Ratio | 121.41 |
| Normalized PE Ratio | 18.28 |